Abbott Medical Devices Trading (Shanghai) Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"

Phase 2

Completed

Conditions: Carotid Atherosclerosis
Carotid Artery Disease

Interventions: Device: Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system

First Posted Date: 2005-09-16

Last Posted Date: 2008-09-12

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 581

Registration Number: NCT00180518

Vision II: Evaluation of GALILEO Intravascular Radiotherapy System

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Device: Guidant GALILEO Intravascular Radiotherapy System

First Posted Date: 2005-09-16

Last Posted Date: 2008-08-01

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 268

Registration Number: NCT00180583

Locations: 🇫🇷
Clinique St. Hilaire, Rouen, France

Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease

Phase 3

Terminated

Conditions: Renal Artery Obstruction

First Posted Date: 2005-09-16

Last Posted Date: 2008-07-28

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 167

Registration Number: NCT00180544

Locations: 🇺🇸
Alton Ochsner Medical Foundation, New Orleans, Louisiana, United States

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Completed

Conditions: Coronary Restenosis
Coronary Disease
Coronary Artery Disease

First Posted Date: 2005-09-16

Last Posted Date: 2010-05-25

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 697

Registration Number: NCT00180466

Locations: 🇺🇸
Good Samaritan Hospital, San Jose, California, United States
🇺🇸
Stanford Hospital and Clinics, Stanford, California, United States
🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States

and more 37 locations

ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries

Phase 4

Completed

Conditions: Peripheral Vascular Diseases

First Posted Date: 2005-09-16

Last Posted Date: 2010-02-24

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 120

Registration Number: NCT00180505

Locations: 🇧🇪
CHR de Namur, Namur, Belgium
🇩🇪
Universitäres Herz & Gefässzentrum Hamburg, Hamburg, Germany
🇮🇹
Policlinico San Matteo, Pavia, Italy

and more 10 locations

Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study

Phase 4

Completed

Conditions: Arrhythmia

Interventions: Device: Autointrinsic Conduction Search Algorithm

First Posted Date: 2005-09-16

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 157

Registration Number: NCT00187239

Locations: 🇺🇸
AtlantiCare Regional Medical Center, Pomona, New Jersey, United States

DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)

Not Applicable

Completed

Conditions: Congestive Heart Failure
Ventricular Fibrillation
Sudden Cardiac Death
Ventricular Tachycardia

Interventions: Device: Implantable Defibrillator (ICD)

First Posted Date: 2005-09-16

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 600

Registration Number: NCT00187187

Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization

Not Applicable

Completed

Conditions: Atrioventricular Block
Ventricular Dysfunction

Interventions: Device: RV Pacing
Device: Biventricular Pacing

First Posted Date: 2005-09-16

Last Posted Date: 2021-01-25

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1833

Registration Number: NCT00187278

Locations: 🇩🇪
Klinikum der Philipps-Universität Marburg, Marburg, Germany

Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy

Not Applicable

Completed

Conditions: Heart Failure
Atrial Fibrillation
Ventricular Dysfunction

Interventions: Device: Atrial Overdrive Pacing

First Posted Date: 2005-09-16

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 380

Registration Number: NCT00187252

Locations: 🇮🇹
Clinica Medica Generale e Cardiologia - Ospedale Careggi, Firenze, Italy

Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients

Phase 4

Completed

Conditions: Heart Failure

Interventions: Device: Sequential VV Pacing
Device: Simultaneous VV Pacing

First Posted Date: 2005-09-16

Last Posted Date: 2019-02-05

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 816

Registration Number: NCT00187200

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy